{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:20:16Z","timestamp":1761862816461,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.jcms.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T04:43:25Z","timestamp":1233204205000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction"],"prefix":"10.1016","volume":"37","author":[{"given":"Thomas","family":"M\u00fccke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Haarmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Dietrich","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"H\u00f6lzle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","author":"AAOMS","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10006-005-0670-0","article-title":"Bisphosphonate-associated osteonecrosis of the jaw","volume":"10","author":"Abu-Id","year":"2006","journal-title":"Mund Kiefer Gesichtschir"},{"key":"10.1016\/j.jcms.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.oraloncology.2005.08.001","article-title":"Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases","volume":"42","author":"Bagan","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2002.34071","article-title":"Advances in the biology and treatment of myeloma bone disease","volume":"29","author":"Berenson","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group","volume":"16","author":"Berenson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group","volume":"334","author":"Berenson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcms.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"6258s","DOI":"10.1158\/1078-0432.CCR-06-0840","article-title":"Breast cancer: bisphosphonate therapy for metastatic bone disease","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcms.2008.12.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/sj.leu.2403949","article-title":"Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells","volume":"19","author":"Chuah","year":"2005","journal-title":"Leukemia"},{"issue":"Suppl 7","key":"10.1016\/j.jcms.2008.12.004_bib12","first-page":"S41","article-title":"Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial","volume":"5","author":"Conte","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s100670050116","article-title":"Severe oral ulcerations induced by alendronate","volume":"18","author":"Demerjian","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jcms.2008.12.004_bib14","first-page":"475","article-title":"Adverse effects of bisphosphonates: current issues","volume":"5","author":"Diel","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib15","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jcms.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.joms.2006.07.012","article-title":"Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?","volume":"65","author":"Engroff","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"Suppl 2","key":"10.1016\/j.jcms.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1007\/s00586-003-0622-z","article-title":"Bisphosphonates in osteoporosis","volume":"12","author":"Fleisch","year":"2003","journal-title":"Eur Spine J"},{"key":"10.1016\/j.jcms.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1034\/j.1600-0714.2000.291006.x","article-title":"Alendronate-related oral mucosa ulcerations","volume":"29","author":"Gonzalez-Moles","year":"2000","journal-title":"J Oral Pathol Med"},{"issue":"Suppl 4","key":"10.1016\/j.jcms.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","article-title":"Bisphosphonates: preclinical review","volume":"9","author":"Green","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.jcms.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0773.1997.tb01964.x","article-title":"Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models","volume":"80","author":"Green","year":"1997","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.jcms.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and osteonecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jcms.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00006534-198907000-00014","article-title":"Fibula free flap: a new method of mandible reconstruction","volume":"84","author":"Hidalgo","year":"1989","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcms.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcms.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jcms.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00268-001-0060-1","article-title":"Free vascularized bone grafts for reconstruction of traumatic bony defects of mandible and maxilla","volume":"25","author":"Kildal","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","article-title":"Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity","volume":"117","author":"Lugassy","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jcms.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1939-1676.2004.tb02593.x","article-title":"Bisphosphonates and cancer","volume":"18","author":"Milner","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jcms.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","article-title":"The antineoplastic role of bisphosphonates: from basic research to clinical evidence","volume":"14","author":"Santini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2008.12.004_bib36","first-page":"389","article-title":"Antiresorptive dose-response relationships across three generations of bisphosphonates","volume":"15","author":"Sietsema","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.jcms.2008.12.004_bib37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1258\/0004563011901037","article-title":"Bisphosphonates: an overview with special reference to alendronate","volume":"38","author":"Vasikaran","year":"2001","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jcms.2008.12.004_bib38","first-page":"193","article-title":"Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy","volume":"25","author":"Vogel","year":"2002","journal-title":"Med Monatsschr Pharm"},{"key":"10.1016\/j.jcms.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00003495-200363040-00009","article-title":"Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jcms.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518208002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518208002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:23:49Z","timestamp":1760883829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518208002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1010518208002266"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2008.12.004","relation":{},"ISSN":["1010-5182"],"issn-type":[{"type":"print","value":"1010-5182"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2008.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 European Association for Cranio-Maxillofacial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}